RECRUITING

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

Official Title

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization (ROMPER): A Randomized Clinical Trial

Quick Facts

Study Start:2025-09-09
Study Completion:2030-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06565390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:22 Weeks to 6 Months
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Infants being discharged from the NICU
  2. * Off all respiratory support (oxygen, CPAP, ventilator) before discharge home
  3. * Gestational age ≥ 22 0/7 weeks' gestation at birth
  4. * Parents/legal guardians have provided consent for enrollment
  1. * a major malformation, a neuromuscular condition that affects respiration or causes apnea, complex congenital heart disease and hemodynamically significant shunts, or terminal illness or decision to withhold or limit support.
  2. * Infants being discharged from the neonatal intensive care unit (NICU) with a cardiorespiratory monitor or respiratory support are not eligible for inclusion.

Contacts and Locations

Study Contact

Kimberly Armstead, BS
CONTACT
205-934-0095
karmstead@uabmc.edu
Rachel Benz, MSN
CONTACT
205-934-4680
rbenz@uabmc.edu

Principal Investigator

Colm P Travers, M.D.
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35249
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Colm P Travers, M.D., PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-09-09
Study Completion Date2030-12-31

Study Record Updates

Study Start Date2025-09-09
Study Completion Date2030-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Emergencies